In situ tumor model for longitudinal in silico imaging trials.

Imagings In Silico mammography tumor modeling

Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
12 Mar 2024
Historique:
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 12 3 2024
Statut: aheadofprint

Résumé

In this article, we introduce a computational model for simulating the growth of breast cancer
lesions accounting for the stiffness of surrounding anatomical structures.
Approach: In our model, ligaments are classified as the most rigid structures while the softer parts of the
breast are occupied by fat and glandular tissues As a result of these variations in tissue elasticity, the rapidly
proliferating tumor cells are met with differential resistance. It is found that these cells are likely to circumvent
stiffer terrains such as ligaments, instead electing to proliferate preferentially within the more yielding confines of
the breast's soft topography. By manipulating the interstitial tumor pressure in direct proportion to the elastic
constants of the tissues surrounding the tumor, this model thus creates the potential for realizing a database
of unique lesion morphology sculpted by the distinctive topography of each local anatomical infrastructure.
We modeled the growth of simulated lesions within volumes extracted from fatty breast models, developed by
Graff et al., with a resolution of 50 μm generated with the open-source and readily available VICTRE (Virtual
Imaging Clinical Trials for Regulatory Evaluation) imaging pipeline. To visualize and validate the realism of
the lesion models, we leveraged the imaging component of the VICTRE pipeline, which replicates the Siemens
Mammomat Inspiration mammography system in a digital format. This system was instrumental in generating
digital mammogram (DM) images for each breast model containing the simulated lesions.
Results: By utilizing the DM images, we were able to effectively illustrate the imaging characteristics of the
lesions as they integrated with the anatomical backgrounds.
Significance: The lesion growth model will facilitate and enhance longitudinal in silico trials investigating the
progression of breast cancer.

Identifiants

pubmed: 38471177
doi: 10.1088/1361-6560/ad3322
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Creative Commons Attribution license.

Auteurs

Aunnasha Sengupta (A)

Division of Diagnostics, Imaging and Software Reliability, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, Maryland, 20903-1058, UNITED STATES.

Miguel Lago (M)

Imaging Physics Laboratory Division of Imaging and Applied Mathematics Office of Science and Engineering Laboratories CDRH, US Food and Drug Administration, 10903 New Hampshire Avenue, WO62, R3116, Silver Spring, MD 20993-0002USA, Silver Spring, Maryland, 20903-1058, UNITED STATES.

Aldo Badano (A)

Imaging Physics Laboratory Division of Imaging and Applied Mathematics Office of Science and Engineering Laboratories CDRH, US Food and Drug Administration, 10903 New Hampshire Avenue, WO62, R3116, Silver Spring, MD 20993-0002USA, Silver Spring, Maryland, 20903-1058, UNITED STATES.

Classifications MeSH